First Page | Document Content | |
---|---|---|
![]() Date: 2010-10-13 11:07:56Pharmaceutical industry Patent law Law Intellectual property law Test data exclusivity Supplementary protection certificate Biosimilar Generic drug European Medicines Agency Pharmaceutical sciences Pharmacology Pharmaceuticals policy | Source URL: ec.europa.euDownload Document from Source WebsiteFile Size: 2,60 MBShare Document on Facebook |
![]() | Trial results: Modalities and timing of posting VersionAprilInterventional Clinical Trials that ended on or after 21 Julyi.e. the date of finalisation of the programming according to Commission GuiDocID: 1r4sk - View Document |
![]() | emea_strap_url_cmyk_rev_en_std_cent.eps MASTERDocID: 1qVx6 - View Document |
![]() | Question Q202 National Group: Sweden Suède Schweden Title:DocID: 1qeRN - View Document |
![]() | B.12 AF user guide consolidated vet version EMADocID: 1pz2w - View Document |
![]() | DOC DocumentDocID: 1oZjJ - View Document |